NCT04310111View on ClinicalTrials.gov

EUS-RFA for Unresectable Pancreatic Cancer

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

July 25, 2021

Study Completion Date

August 25, 2021

Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
PROCEDURE

EUS-RFA

Use EUS-RFA to treat unresectable pancreatic cancer

Trial Locations (1)

31006

Hangzhou First People's Hospital, Hangzhou

All Listed Sponsors
lead

First People's Hospital of Hangzhou

OTHER

NCT04310111 - EUS-RFA for Unresectable Pancreatic Cancer | Biotech Hunter | Biotech Hunter